Published: Aug. 27, 2024
Background: Contrast-induced acute kidney injury (CIAKI) is a common complication in hospital-acquired renal conditions, yet its pathogenesis remains unclear and effective treatments are limited. Intermedin (IMD), peptide related to the calcitonin gene, exhibits vasodilatory endothelial barrier-stabilizing effects via receptor-like receptor (CLR). However, potential of IMD mitigating CIAKI has not been thoroughly investigated. Aims: This study aimed delineate protective role through both vitro vivo models, with particular focus on elucidating underlying mechanisms, specifically cAMP/Rac1 signaling pathway. Methods: Human umbilical vein cells (HUVECs) were treated iohexol simulate vitro. The evaluated using CCK8 assay, flow cytometry, ELISA, western blotting. A rat model was developed assess peritubular capillary cell function range techniques, including histopathology, immunohistochemistry, immunofluorescence, blotting, transmission electron microscopy. Results: In vitro, significantly enhanced HUVEC viability mitigated iohexol-induced toxicity by preserving intercellular adhesion junctions activating attenuated Rac1 inhibition. vivo, caused considerable damage junctions, leading impaired function. treatment markedly improved function, an effect that abolished Conclusion: protects against pathway, thereby integrity induced contrast media. These findings underscore therapeutic emphasize critical pathway protection.
Language: Английский